C. Diff Test: Toxin, PCR and What a Positive Means

C. Diff Test: Toxin, PCR and What a Positive Means

Severe belly pain, a swollen or distended belly, a fever, or a very high white blood cell count alongside diarrhea need emergency care. Call 911 or go to the nearest emergency department rather than waiting for a stool result.

What does this stool test actually look for?

It looks for a short stretch of bacterial DNA, usually the gene that codes for toxin B, rather than for the toxin protein itself. The laboratory takes a small amount of an unformed stool sample, releases the DNA in it, and amplifies the target sequence through repeated heating and cooling cycles. If the target sequence is there, the reaction crosses a detection threshold and the result is reported as positive.

Because amplification multiplies even a trace of starting material, the method finds very small numbers of organisms. That sensitivity is both its strength and its weakness. A positive tells you that an organism carrying the instructions for toxin production is present in the gut. It does not tell you that toxin is being made right now, or that this organism is the reason for the diarrhea. Separating true infection from simple carriage is the central difficulty in laboratory diagnosis of this organism 1.

Clostridioides difficile, formerly called Clostridium difficile, is a spore forming bacterium that lives in the large intestine. Illness happens when the organism multiplies and releases toxins that inflame the lining of the colon, producing watery diarrhea, cramping and sometimes fever. The PCR step only answers one narrow question in that chain, which is whether the genetic capacity for toxin production is present in the sample.

Why does the three loose stools in 24 hours rule matter?

That threshold exists because testing people who are not having significant diarrhea mostly finds carriers rather than illness. Asymptomatic carriage of this organism is common, particularly among adults who have spent time in healthcare settings, and carriers can be positive on sensitive molecular testing while feeling perfectly well 2.

The practical rule used by most laboratories is three or more unformed or watery stools within 24 hours, with no other obvious explanation, before a sample is accepted. Many laboratories reject formed stool outright, because a formed sample is not consistent with active colitis and a positive on it is far more likely to reflect carriage. Current guidance from major professional groups converges on restricting testing to patients with clinically significant diarrhea and on avoiding testing of formed stool 3.

There is a second reason the threshold matters. A positive result follows a person through their chart. It can trigger isolation precautions in hospital, shape decisions about care, and sit in the record as a prior episode that influences how future symptoms are interpreted. A result generated from a sample that should never have been collected still carries all of that weight, which is why the decision to test is a clinical one made before the cup is ever handed over.

How does PCR differ from a toxin test?

PCR detects the gene for toxin, while a toxin immunoassay detects the toxin protein sitting in the stool, and that difference drives everything else about how the two results are read. A gene can be present without being switched on. Toxin in the stool is closer to the thing that actually injures the colon.

Test What it detects Main strength Main limitation
PCR, also called NAAT The toxin gene in bacterial DNA Very sensitive, rarely misses the organism A positive can reflect carriage rather than active illness
Toxin A/B immunoassay Free toxin protein in stool A positive points to toxin being produced now Less sensitive, can miss some true infection
GDH antigen An enzyme made by the organism whether or not it produces toxin Fast, inexpensive, very few false negatives Cannot show whether the strain makes toxin
Toxigenic culture Growth of the organism, then testing the isolate for toxin genes Reference method, allows strain typing Slow and labour intensive
Cell cytotoxicity neutralisation assay Toxin activity in cultured cells Historic reference for free toxin Slow, available in few laboratories

Laboratory methods for this organism have shifted over time from culture and cell based toxin detection toward antigen and molecular testing, and each generation of methods traded speed against the ability to say something about toxin 5. Research suggests that the testing strategy a laboratory adopts changes how many cases it reports and how patients are subsequently managed, because a sensitive molecular approach and a toxin first approach do not flag the same group of people 4.

What does the GDH antigen step add?

GDH, or glutamate dehydrogenase, is an enzyme produced in large amounts by C. difficile, and the antigen test for it works as a fast, inexpensive screen for the organism's presence. It is highly sensitive, so a negative GDH makes the organism unlikely to be in the sample at all, which lets a laboratory close out most negative cases quickly and cheaply.

What GDH cannot do is distinguish a toxin producing strain from a harmless non toxigenic one, because both make the enzyme. That is why GDH is almost never used alone. It is a gate. A negative closes the pathway, and a positive opens a second step that asks the more specific question about toxin or about the toxin gene. This layered approach is part of how laboratory diagnosis evolved, with antigen screening sitting between older culture based work and molecular detection 5.

For a reader looking at a result slip, a GDH line on its own means very little. It is the combination with the toxin or PCR line that carries the information, which is the subject of the next two sections.

How do laboratories combine these into an algorithm?

Most laboratories use a two step or three step algorithm rather than a single test, because no single method answers both questions that matter. A common pattern starts with GDH antigen and a toxin immunoassay run together. If both agree, the answer is reported. If they disagree, a molecular test acts as the tiebreaker. Another common pattern starts with a sensitive molecular test and adds a toxin immunoassay to any positive, so the clinician sees both the gene result and the toxin result.

Major guidelines from different professional bodies do not agree on a single preferred algorithm, and they differ in how much weight they give to free toxin detection versus molecular detection, while agreeing that testing should be limited to patients with clinically significant diarrhea 3. That is why two hospitals can run different pathways on the same sample and report the result in different words.

The practical consequence is worth knowing. If a result slip only says positive or negative, it is reasonable to ask the ordering clinician which method produced it and whether a toxin result is available, because the two carry different weight when symptoms are mild or when another explanation for diarrhea is in play.

Can a positive result mean carriage rather than infection?

Yes, and this is the single most important limitation of a highly sensitive molecular result. Carriage means the organism lives in the gut without causing illness, and it is well described in adults, particularly those with recent healthcare contact 2. In a carrier with diarrhea from a different cause, a PCR test will still be positive, and the real reason for the symptoms can be missed.

This is where the toxin result earns its place. A patient who is PCR positive and toxin negative sits in an ambiguous group, and distinguishing infection from colonization in that group remains the hardest part of diagnosis 1. Studies indicate that ultrasensitive measurement of toxin concentration in stool may help separate patients with true infection from those who are simply carrying the organism, by quantifying toxin rather than reporting a yes or no 6.

None of this means a positive should be waved away. It means the result is one input. The clinician weighs it against the stool pattern, how unwell the person looks, how the symptoms started, and what else could explain them. Observation, then interpretation, then a conversation with the clinician who ordered the test.

How should the different result combinations be read?

Read them as a picture rather than a verdict, with the toxin line indicating current toxin production and the molecular line indicating the organism's presence and capacity. The table below shows the common patterns and what each may reflect. None of these rows is a diagnosis, and the final interpretation belongs to the clinician who knows the full clinical picture.

GDH Toxin immunoassay PCR / NAAT What it may reflect Reasonable next step
Negative Negative Not usually needed This organism is an unlikely explanation for the symptoms Clinician looks at other causes of diarrhea
Positive Positive Not usually needed Organism present and toxin detected, consistent with active infection Clinician reviews symptoms and severity promptly
Positive Negative Positive Toxin gene present, free toxin not detected, infection or carriage both possible Clinician weighs symptoms, severity markers and alternative causes
Positive Negative Negative Discrepant result, infection less likely Clinician reviews other explanations
Negative Positive Variable Uncommon pattern, often a technical issue Laboratory repeats or confirms before the result is relied on

Because the toxin negative, gene positive group is so common in practice, the wording on a report matters. Detected can mean the gene only. The clinician reading it will know which assay produced which line, and asking that question directly is reasonable.

What does a negative result rule out, and should testing be repeated?

A negative molecular result makes this organism an unlikely cause of the current diarrhea, because the method is sensitive enough that a true infection with ongoing symptoms is rarely missed. That is the main value of a sensitive test, a negative that can be relied on.

The organism and its gene can persist in stool well after a person feels better, so a follow up test is not used to confirm that an episode has ended, and a positive at that point would not mean the illness has returned. Guidance consistently advises against repeat testing as a test of resolution.

What does justify further testing is a genuine change, new or worsening symptoms, a different clinical course, or a new episode after a symptom free period. That decision is a clinical one. Research suggests that how often a service tests, and whom it tests, shapes the reported case numbers as much as the underlying illness does 4.

How is the sample collected and handled?

The sample is a single unformed stool collected into a clean, dry, leak proof container provided by the laboratory, with no urine, toilet water or toilet paper mixed in. Most collection kits include a scoop in the lid and a line showing roughly how full the container should be.

A few practical points make the difference between a usable sample and a rejected one. The stool needs to take the shape of the container, since formed samples are usually declined. Contamination with urine or cleaning products can interfere with the assay. The container should be labelled with the name and date exactly as the laboratory asks, sealed, and returned promptly. If there is a delay, most laboratories ask for refrigeration rather than freezing, and the specific instructions on the kit take priority over general advice.

One sample is normally enough. Sending several samples from the same episode does not improve the answer and slows the laboratory down. Turnaround time depends on the laboratory and on whether the molecular platform runs continuously or in batches, so the realistic answer comes from the ordering clinician rather than from a general figure. There is no fasting, no diet change and no scan preparation involved in collecting stool.

Why do hospitals limit who can be tested?

Hospitals restrict ordering because a sensitive test applied to the wrong patients produces positives that reflect carriage, and those positives change care. This practice of defining who may be tested, and on what sample, is often called diagnostic stewardship. It typically includes rejecting formed stool, blocking repeat orders within a set window, and requiring documentation of the stool frequency before the sample is accepted.

The reason is practical rather than bureaucratic. Testing choices influence reported infection rates, isolation decisions and downstream management, so the same patient population can look very different depending on which pathway a hospital uses 4. Transmission of this organism in healthcare settings is driven by spores that survive on surfaces and hands, which is why a positive result also triggers environmental and contact precautions 2.

For an outpatient, the same logic applies in a gentler form. A clinician who declines to order the test on a day with one loose stool is not dismissing the symptom. They are avoiding a result that would be hard to interpret and easy to over read.

What else can produce the same symptoms?

Plenty, which is exactly why a positive gene result alone does not close the question. Acute watery diarrhea in adults can follow other gut infections, both bacterial and viral. It can follow a change in diet, a large change in fibre intake, or a bout of food poisoning that resolves on its own.

Some medicines upset bowel habit, and recent changes to what someone takes are worth raising with the prescriber rather than guessing at. Longer running patterns can reflect conditions that cause inflammation in the bowel, or disorders of gut function where the bowel is structurally normal but symptoms persist. In people with inflammatory bowel conditions, flares and infection can look similar and can occur together, which is one reason stool testing and clinical assessment are done side by side.

The honest summary is that stool frequency and consistency are a symptom, not a diagnosis. A single test answers a single question. If the result is negative and the symptoms continue, the useful next conversation is about what else fits, not about repeating the same test. You can read more about the symptom pattern itself in the linked guide below.

What does a white cell count measure, and where does it fit here?

Total WBCs is the count of circulating white blood cells, the cells that drive the immune response, reported in thousands per microlitre. The dedicated guide covers how the marker is measured and how to read a result in detail. In the setting of acute colitis, the count is one of the inputs a clinician uses when judging how unwell someone is, alongside symptoms and kidney function markers 7. Compare your result with the range printed on your lab report. FitScript's optimal range for Total WBCs is 3.8 to 6 K/µL, an optimization target rather than a diagnostic cut-off. Reference ranges vary by laboratory, age and sex. A count well outside the reference range during an acute illness is worth discussing with a clinician promptly.

Which other blood markers are often checked alongside the stool test?

When someone is unwell enough for this test to be ordered, blood work usually runs in parallel to describe how the body is coping, not to confirm the infection. Severe illness is associated with a rising white cell count and with worsening kidney function markers, and those two inputs sit at the centre of how clinicians grade severity 7.

Marker What it adds in this setting
Total WBCs A broad signal of how strongly the immune system is responding
Creatinine Reflects kidney function, which can shift when fluid losses are large
Electrolytes Sodium, potassium and chloride move with heavy diarrhea
Albumin A low value can accompany significant gut inflammation and losses
C reactive protein A general inflammation signal, non specific and read with everything else
Lactate Sometimes checked in acute assessment when illness looks severe

Compare your result with the range printed on your lab report. C reactive protein is reported differently across laboratories, so it is read against that laboratory's own reference rather than a universal number. At FitScript, testing covers 150+ biomarkers tested per year, with interpretation by Atlas, the AI health advisor, while any treatment decision belongs to a licensed provider.

What usually happens after a positive result?

The clinician reviews the result against the symptoms, grades how severe the episode looks, and decides on care, which may include hydration support and specific management. No drug, product or regimen should be started on the basis of a result slip alone. Treatment decisions belong to a licensed provider who has assessed the person.

Two practical points are worth knowing in advance. The first is infection control. Because spores spread readily on hands and surfaces, careful handwashing with soap and water and attention to shared bathrooms are standard advice during an episode, and hospitals add contact precautions. The second is recurrence. Research suggests that a further episode after an initial one is a recognised feature of this infection, which is why clinicians often discuss what to watch for after symptoms settle 8.

If symptoms return weeks later, the right move is to contact the clinician who managed the first episode rather than assuming the pattern is identical. Recurrent symptoms are assessed clinically, and the decision about whether to test again rests on that assessment.

When is it time to talk to a clinician?

Any adult with three or more loose stools in 24 hours that has no obvious explanation should contact a clinician, and that conversation is what determines whether stool testing is appropriate at all. Sooner is better when symptoms follow a recent hospital stay or a recent change in medicines, which is a question for the prescriber.

Some features need urgent attention rather than an appointment. Severe or worsening belly pain, a swollen or distended belly, a fever, blood in the stool, signs of significant dehydration such as dizziness on standing or passing very little urine, or a white blood cell count reported as very high, all warrant emergency care. Call 911 or attend an emergency department.

This article is educational and is not medical advice. Discuss your symptoms, your results and any treatment decision with a clinician or licensed provider who knows your history, and never ignore an abnormal result on the assumption that it reflects carriage.

Key takeaways

For more on the symptom pattern that leads to this test being ordered, see the guide to c diff symptoms.

References

  1. Clostridioides difficile Infection: Diagnosis and Treatment Challenges. Pathogens (Basel, Switzerland), 2024.
  2. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nature Reviews. Gastroenterology & Hepatology, 2016.
  3. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines. The Journal of Antimicrobial Chemotherapy, 2022.
  4. Diagnosis of Clostridioides difficile infection and impact of testing. Journal of Medical Microbiology, 2024.
  5. Laboratory diagnosis of Clostridioides difficile infection: past, present and future. Anaerobe, 2025.
  6. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy. Journal of Clinical Microbiology, 2020.
  7. Diagnosis and Management of Clostridioides difficile. The American Journal of Gastroenterology, 2026.
  8. Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives. The American Journal of Medicine, 2024.

Common questions

Does a positive PCR result always mean I have an active infection?

No. The molecular test finds the gene that allows the bacterium to make toxin, which can be present in someone who carries the organism without being ill. A clinician reads the result alongside your stool pattern, how unwell you feel and any toxin result before deciding what it means. If your symptoms are mild or there is another likely explanation, say so when you discuss the result.

What is the difference between the PCR test and the toxin test?

The PCR test looks for bacterial DNA, specifically the gene for toxin production. The toxin test looks for the toxin protein itself in the stool sample, which is closer to what actually irritates the colon. Many laboratories report both, because the gene can be present without toxin being produced at that moment.

Can my stool be tested if it is formed?

Usually not. Most laboratories only accept unformed or watery stool that takes the shape of the container, because a formed sample is not consistent with active colitis. If a formed sample is submitted, it is often rejected, and a positive on one would be hard to interpret. The usual trigger for testing is three or more loose stools within 24 hours with no clear explanation.

How long do results take?

Turnaround depends on the laboratory and on whether its molecular platform runs samples continuously or in batches, so there is no single answer. Ask the clinician or the laboratory that issued the collection kit for their current timing. If you are unwell while waiting, contact your clinician rather than waiting for the result.

Do I need to prepare before collecting the sample?

There is no fasting, diet change or special preparation. Collect the stool into the clean container provided, keeping urine, toilet water and toilet paper out of it, then label and seal it as the kit instructs. If there will be a delay before it reaches the laboratory, follow the storage instruction on the kit, which is usually refrigeration.

Should I be retested once my symptoms settle?

Generally no. The organism and its gene can stay detectable in stool after you feel better, so a repeat test is not used to confirm that an episode has ended and a positive at that point would be misleading. Retesting is considered when symptoms change or a new episode begins, and that call belongs to your clinician.

Can this infection come back after it clears?

A further episode after an initial one is recognised, so it is worth knowing what to watch for after symptoms settle. If diarrhea returns weeks later, contact the clinician who managed the first episode rather than assuming it is the same thing. They decide whether another sample is needed and what happens next.

Which blood tests might be run at the same time?

A white blood cell count, creatinine for kidney function, electrolytes, albumin and a general inflammation marker are commonly checked when someone is unwell with diarrhea. These describe how your body is coping rather than confirming the infection itself. Your clinician decides which of them apply to your situation and how to read them together.

Related reading